Articles from Prime Radiant Partners

Prime Radiant Partners (“Prime Radiant”), a new advisory firm specializing in middle-market private equity investments focused on companies delivering next generation services and technologies within the healthcare and life sciences industries, today announced that Prime Radiant Fund SLP SICAV-RAIF, a fund advised by Prime Radiant, has made a $50 million growth equity investment in Cellares, the first-of-its-kind Integrated Development and Manufacturing Organization (IDMO) working to automate the large-scale manufacturing of cutting-edge cell therapies. Prime Radiant joins a high-caliber group of Cellares investors, including investment funds managed by BlackRock, Eclipse, T. Rowe Price Investment Management, Inc., Baillie Gifford, Duquesne Family Office, Intuitive Ventures, EDBI, Gates Frontier, DC Global Ventures, Willett Advisors, DFJ Growth, and ARK Invest. The partnership with Cellares marks Prime Radiant’s advised funds’ inaugural investment since the firm’s launch in 2025.